Specific induction of pp125 focal adhesion kinase in human breast cancer

The pp125 focal adhesion kinase (FAK) is involved in integrin-mediated cell signalling and overexpressed in a variety of solid tumours. Focal adhesion kinase expression has been correlated to invasion and metastasis, but the data on breast cancer are inconclusive. We analysed FAK mRNA, protein levels and expression patterns in primary breast cancer and normal breast tissue. FAK expression on the functional protein level and mRNA was determined in 55 matched pairs of breast cancer and corresponding normal tissue by Western blot, immunohistochemistry and RT–PCR. Using a score ranging from 0 to +5 for Western blots, we determined in normal breast tissue a score of 1.51±0.84 (mean±standard deviation), which was strongly induced to 2.91 (±1.22) in breast cancers (P<0.001). Overall, 45 out of 55 tissue pairs (81.8%) showed this upregulation of FAK protein in tumours in comparison to normal tissue. Immunohistochemistry confirmed these findings with a significant higher score for tumours vs physiological tissue (1.0±0.63 vs 2.27±0.91; P=0.001). Interestingly, no overall significant difference in the mRNA levels (P=0.359) was observed. In conclusion, expression levels of the FAK protein are specifically upregulated in breast cancer in comparison to matched normal breast tissue supporting its pivotal role in neoplastic signal transduction and representing a potential marker for malignant transformation.

• Publication year

  2005

• Venue

  British Journal of Cancer

• Publication date

  2005-08-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.bjc.6602744PMID 16136050PMCID 2361616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype

  2005influential reference
• High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome

  2005cited by this paper
• Focal adhesion kinase: the first ten years

  2003cited by this paper
• Focal adhesion kinase N-terminus in breast carcinoma cells induces rounding, detachment and apoptosis.

  2003cited by this paper
• Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas.

  2003influential reference
• Heregulin and HER2 signaling selectively activates c‐Src phosphorylation at tyrosine 215

  2003cited by this paper
• Inhibition of focal adhesion kinase by antisense oligonucleotides enhances the sensitivity of breast cancer cells to camptothecins.

  2003cited by this paper
• hsp72 Inhibits Focal Adhesion Kinase Degradation in ATP-depleted Renal Epithelial Cells*

  2003cited by this paper
• αv integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells

  2003cited by this paper
• alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells.

  2003cited by this paper
• Molecular Mechanisms in Signal Transduction: New Targets for the Therapy of Gynecologic Malignancies

  2002cited by this paper
• Expert Commentary.

  2002cited by this paper
• Dual Inhibition of Focal Adhesion Kinase and Epidermal Growth Factor Receptor Pathways Cooperatively Induces Death Receptor-mediated Apoptosis in Human Breast Cancer Cells*

  2002cited by this paper
• Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells.

  2001cited by this paper
• p125 focal adhesion kinase promotes malignant astrocytoma cell proliferation in vivo.

  2000cited by this paper
• Signaling—2000 and Beyond

  2000cited by this paper
• Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes.

  2000influential reference
• Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells

  1999influential reference
• Dephosphorylation of Focal Adhesion Kinase (FAK) and Loss of Focal Contacts Precede Caspase-mediated Cleavage of FAK during Apoptosis in Renal Epithelial Cells*

  1999cited by this paper
• Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma

  1999cited by this paper
• Pathological prognostic factors in breast cancer.

  1999cited by this paper
• Focal adhesion kinase pp125FAK and the beta 1 integrin subunit are constitutively complexed in HaCaT cells.

  1998cited by this paper
• Regulation of the Cell Cycle by Focal Adhesion Kinase

  1998cited by this paper
• Caspases Cleave Focal Adhesion Kinase during Apoptosis to Generate a FRNK-like Polypeptide*

  1998cited by this paper
• Role of tyrosine specific phosphorylation of cellular proteins, especially EGF receptor and p125FAK in human lung cancer cells.

  1997cited by this paper
• Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18

  1997cited by this paper
• Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells.

  1996cited by this paper
• Inhibition of pp125FAK in cultured fibroblasts results in apoptosis

  1996cited by this paper
• Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn.

  1996cited by this paper
• Adhesion systems in normal breast and in invasive breast carcinoma.

  1995cited by this paper
• Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors.

  1995cited by this paper
• Focal adhesion kinase (p125FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes.

  1992cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper
• Signal transduction by receptors with tyrosine kinase activity.

  1990cited by this paper

• FAK signaling pathways are modulated by HSPB8 and BAG3 in breast cancer.

  2026cites this paper
• The Effect of Adipocyte-Secreted Factors in Activating Focal Adhesion Kinase-Mediated Cell Signaling Pathway towards Metastasis in Breast Cancer Cells

  2023cites this paper
• Immunoglobulin superfamily 9 (IGSF9) is trans-activated by p53, inhibits breast cancer metastasis via FAK

  2022cites this paper
• Functional and clinical characteristics of focal adhesion kinases in cancer progression

  2022cites this paper
• Downregulation of microRNA-4324 promotes the EMT of esophageal squamous-cell carcinoma cells via upregulating FAK

  2019cites this paper
• Glutathione peroxidase-1 regulates adhesion and metastasis of triple-negative breast cancer cells via FAK signaling

  2019cites this paper
• Emerging Medical Treatments for Meningioma in the Molecular Era

  2018cites this paper
• Thyroid Hormone Controls Breast Cancer Cell Movement via Integrin αV/β3/SRC/FAK/PI3-Kinases

  2017cites this paper
• Role of Protein Kinases and Their Inhibitors in Radiation Response of Tumor Cells.

  2017cites this paper
• Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells

  2016cites this paper
• Expression of pY397 FAK promotes the development of non-small cell lung cancer

  2015cites this paper
• Identification of novel Focal Adhesion Kinase binding partners and their biological functions in cancer cells

  2015cites this paper
• Focal Adhesion Kinase (FAK) as a novel therapeutic target in HER2+ breast cancer

  2015cites this paper
• MiR-578 and miR-573 as potential players in BRCA-related breast cancer angiogenesis

  2014cites this paper
• Design of novel focal adhesion kinase inhibitors using 3D-QSAR and molecular docking

  2014cites this paper
• Naphtho[1,2-b]furan-4,5-dione inhibits MDA-MB-231 cell migration and invasion by suppressing Src-mediated signaling pathways

  2013cites this paper
• Proteomic identification of putative biomarkers of neo-adjuvant chemotherapy resistance in luminal (ER+) breast cancer

  2013cites this paper
• Benzo-[a]-pyrene induces FAK activation and cell migration in MDA-MB-231 breast cancer cells

  2013cites this paper
• Krüppel‑like factor expression and correlation with FAK, MMP‑9 and E‑cadherin expression in hepatocellular carcinoma.

  2013cites this paper
• Inhibition of Src activation with cardiotoxin III blocks migration and invasion of MDA-MB-231 cells.

  2013cites this paper
• Studies on Focal Adhesion Kinase in Human Breast Cancer Tissue

  2012cites this paper
• Focal adhesion kinase-regulated signaling events in human cancer

  2012cites this paper
• Acquired endocrine resistance in breast cancer: implications for tumour metastasis.

  2011cites this paper
• RAS Interaction with PI3K: More Than Just Another Effector Pathway.

  2011cites this paper
• The interaction of focal adhesion kinase with apoptotic regulators underpins anoikis resistance in human oesophageal carcinoma

  2011cites this paper
• β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer

  2011cites this paper
• Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways.

  2011cites this paper
• Tumorigenesis and Neoplastic Progression Focal Adhesion Kinase-Related Proline-Rich Tyrosine Kinase 2 and Focal Adhesion Kinase Are Co-Overexpressed in Early-Stage and Invasive ErbB2-Positive Breast Cancer and Cooperate for Breast Cancer Cell Tumorigenesis and Invasiveness

  2010cites this paper
• Focal adhesion kinase mediates TGF-β1-induced renal tubular epithelial-to-mesenchymal transition in vitro

  2010cites this paper
• Focal adhesion kinase serves as a marker of cervical lymph node metastasis and is a potential therapeutic target in tongue cancer

  2010cites this paper
• Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis.

  2010cites this paper
• Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models

  2010cites this paper
• A novel role of ERK5 in integrin‐mediated cell adhesion and motility in cancer cells via Fak signaling

  2009cites this paper
• Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion

  2009cites this paper
• Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells

  2009cites this paper
• The Lysyl Oxidase Pro-peptide Attenuates Fibronectin-mediated Activation of Focal Adhesion Kinase and p130Cas in Breast Cancer Cells*

  2009cites this paper
• How adhesion signals reach a mitochondrial conclusion--ECM regulation of apoptosis.

  2009cites this paper
• Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling.

  2009cites this paper
• Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-β signaling and metastasis

  2009cites this paper
• Dual FGF-2 and Intergrin α5β1 Signaling Mediate GRAF-Induced RhoA Inactivation in a Model of Breast Cancer Dormancy

  2009cites this paper
• Expression of Focal Adhesion Kinase in Patients With Endometrial Cancer: A Clinicopathologic Study

  2009cites this paper
• Focal adhesion kinase as an immunotherapeutic target

  2009cites this paper
• FAK engages multiple pathways to maintain survival of fibroblasts and epithelia – differential roles for paxillin and p130Cas

  2009cites this paper
• Clinical significance of FAK expression in human neoplasia.

  2008influential citation
• Early stage cancer cell invasion: signaling, biomarkers and therapeutic targeting.

  2008cites this paper
• UNIVERSITY OF FLORIDA THESIS OR DISSERTATION FORMATTING TEMPLATE

  2008cites this paper
• Regulation of breast cancer cell growth and survival by the interaction of focal adhesion kinase and vascular endothelial growth factor receptor-3

  2008cites this paper
• TGFβ-induced EMT requires focal adhesion kinase (FAK) signaling

  2008cites this paper
• TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling.

  2008cites this paper
• Focal Adhesion Kinase Expression in Human Neuroblastoma: Immunohistochemical and Real-time PCR Analyses

  2008cites this paper
• SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells

  2008cites this paper
• Untersuchungen an murinen Pinch-1 fl/fl und Pinch-1 -/- Fibroblasten zur Rolle von Pinch-1 für die zelluläre Strahlenreaktion

  2007cites this paper
• Bortezomib inhibits cell-cell adhesion and cell migration and enhances epidermal growth factor receptor inhibitor-induced cell death in squamous cell cancer.

  2007cites this paper
• Rolle der fokalen Adhäsionskinasen in der Signaltransduktion in malignen Leberzellen

  2007cites this paper
• Focal adhesion kinase: a potential target in cancer therapy.

  2007cites this paper
• Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression

  2007cites this paper
• CELL ADHESION-MEDIATED RADIATION RESISTANCE: THE ROLE OF INTEGRINS AND INTEGRIN PROXIMAL PROTEIN

  2006cites this paper
• Weak Expression of Focal Adhesion Kinase (pp125FAK) in Patients with Cervical Cancer Is Associated with Poor Disease Outcome

  2006cites this paper
• Integrin-mediated cell-matrix interactions for prosurvival and antiapoptotic signaling after genotoxic injury.

  2006cites this paper
• Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK

  2006influential citation
• Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model

  2006cites this paper